In silico prediction and in vitro assessment of novel heterocyclics with antimalarial activity.

Autor: Orozco MI; Department of Microbiology, Universidad del Valle, Cali, Colombia., Moreno P; Faculty of Engineering, Universidad del Valle, Cali, Colombia., Guevara M; Faculty of Engineering, Universidad del Valle, Cali, Colombia., Abonia R; Department of Chemistry, Universidad del Valle, Cali, Colombia., Quiroga J; Department of Chemistry, Universidad del Valle, Cali, Colombia., Insuasty B; Department of Chemistry, Universidad del Valle, Cali, Colombia., Barreto M; Department of Microbiology, Group of Microbiology and Infectious Diseases, Universidad del Valle, San Fernando Campus, Calle 4 B #36-00, 760043, Cali, Colombia., Burbano ME; Department of Microbiology, Group of Microbiology and Infectious Diseases, Universidad del Valle, San Fernando Campus, Calle 4 B #36-00, 760043, Cali, Colombia., Crespo-Ortiz MDP; Department of Microbiology, Group of Microbiology and Infectious Diseases, Universidad del Valle, San Fernando Campus, Calle 4 B #36-00, 760043, Cali, Colombia. maria.crespo.ortiz@correounivalle.edu.co.
Jazyk: angličtina
Zdroj: Parasitology research [Parasitol Res] 2023 Dec 29; Vol. 123 (1), pp. 75. Date of Electronic Publication: 2023 Dec 29.
DOI: 10.1007/s00436-023-08089-7
Abstrakt: The development of new antimalarials is paramount to keep the goals on reduction of malaria cases in endemic regions. The search for quality hits has been challenging as many inhibitory molecules may not progress to the next development stage. The aim of this work was to screen an in-house library of heterocyclic compounds (HCUV) for antimalarial activity combining computational predictions and phenotypic techniques to find quality hits. The physicochemical determinants, pharmacokinetic properties (ADME), and drug-likeness of HCUV were evaluated in silico, and compounds were selected for structure-based virtual screening and in vitro analysis. Seven Plasmodium target proteins were selected from the DrugBank Database, and ligands and receptors were processed using UCSF Chimera and Open Babel before being subjected to docking using Autodock Vina and Autodock 4. Growth inhibition of P. falciparum (3D7) cultures was tested by SYBR Green assays, and toxicity was assessed using hemolytic activity tests and the Galleria mellonella in vivo model. From a total of 792 compounds, 341 with good ADME properties, drug-likeness, and no interference structures were subjected to in vitro analysis. Eight compounds showed IC 50 ranging from 0.175 to 0.990 µM, and active compounds included pyridyl-diaminopyrimido-diazepines, pyridyl-N-acetyl- and pyridyl-N-phenyl-pyrazoline derivatives. The most potent compound (UV802, IC 50 0.178 µM) showed no toxicophoric and was predicted to interact with P. falciparum 1-cysperoxidredoxin (PfPrx1). For the remaining 7 hits (IC 50  < 1 μM), 3 showed in silico binding to PfPrx1, one was predicted to bind the haloacid dehalogenase-like hydrolase and plasmepsin II, and one interacted with the plasmodial heat shock protein 90.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: